Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioHarvest Sciences Inc. - Common Stock (NQ:BHST)

3.920 -0.040 (-1.01%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 14,559
Open 4.000
Bid (Size) 3.500 (20,000)
Ask (Size) 4.720 (500)
Prev. Close 3.960
Today's Range 3.910 - 4.048
52wk Range 3.570 - 12.80
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
BioHarvest (BHST) Q1 2026 Earnings Transcript ↗
BioHarvest (BHST) Q1 2026 Earnings Transcript 
Via The Motley Fool
News headline image
Tate & Lyle Expands Collaboration with BioHarvest Sciences to Accelerate Next-Generation Sweetener Innovation
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - May 18, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0), a... 
Via Newsfile

Performance

YTD
-24.8%
-24.8%
1 Month
-11.3%
-11.3%
3 Month
-10.9%
-10.9%
6 Month
-40.7%
-40.7%
1 Year
-39.6%
-39.6%

More News

Read More
News headline image
BioHarvest Sciences Q1 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
BioHarvest Sciences Reports First Quarter 2026 Financial Results and Provides Business Update
Via Newsfile
News headline image
Earnings Scheduled For November 13, 2025 ↗
Via Benzinga
News headline image
BioHarvest Sciences Appoints New Head of Business Development for its CDMO Division
Via Newsfile
News headline image
BioHarvest Sciences Announces Successful Completion of Stage 1 Development of Saffron Composition for Nutraceutical and Culinary Applications
Via Newsfile
Topics Economy
News headline image
BioHarvest Sciences Signs $1.2M CDMO Stage 2 Contract for the Development of a Rare Fragrance Using Its Proprietary Botanical Synthesis Platform
Via Newsfile
News headline image
BioHarvest Sciences to Report First Quarter 2026 Financial Results on May 14, 2026
Via Newsfile
Topics Earnings
News headline image
BioHarvest Sciences Announces Strategic Leadership Transition with Dr. Zaki Rakib Assuming Role of Chief Executive Officer to Accelerate "Two-Lens" Growth Strategy
Via Newsfile
News headline image
BioHarvest Sciences Reports Fourth Quarter and Full-Year 2025 Financial Results
Via Newsfile
News headline image
BioHarvest Sciences Announces First-Ever Successful Stable Cell Culture Development of Rare Fragrance-Producing Plant Using Proprietary Botanical Synthesis Platform
Via Newsfile
News headline image
BioHarvest Sciences Announces that VINIA is Now the No.1 Resveratrol Polyphenol Brand in the United States
Via Newsfile
News headline image
BioHarvest Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026
Via Newsfile
Topics Earnings
News headline image
BioHarvest Sciences Announces Board Transition and Appointment of Prof. Hezi Levy
Via Newsfile
News headline image
BioHarvest Sciences to Participate in 38th Annual Roth Conference on March 22-24, 2026
Via Newsfile
News headline image
BioHarvest Sciences Issues Year End Shareholder Letter
Via Newsfile
News headline image
BioHarvest Sciences Awarded $1.6 Million USD Grant from the Israeli Innovation Authority to Advance Second-Generation Botanical Synthesis Platform
Via Newsfile
Topics Artificial Intelligence
News headline image
BioHarvest Sciences Announces Launch of VINIA Blood Flow Hydration Product
Via Newsfile
News headline image
BioHarvest Sciences Reports Third Quarter 2025 Financial Results
Via Newsfile
News headline image
BioHarvest Sciences Inc. - Common Stock Earnings Preview ↗
Via Benzinga
News headline image
BioHarvest Sciences to Attend the Craig-Hallum 16th Annual Alpha Select Conference on November 18, 2025
Via Newsfile
News headline image
BioHarvest Sciences Announces Closing of $19.9 Million Upsized Public Offering of Common Stock and Exercise of Underwriter's Option to Purchase Additional Shares
Via Newsfile
Topics Earnings Regulatory Compliance
News headline image
BioHarvest Sciences Announces Pricing of $17.4 Million Upsized Public Offering of Common Stock
Via Newsfile
Topics Regulatory Compliance
News headline image
BioHarvest Announces Proposed Public Offering of Common Stock
Via Newsfile
Topics Regulatory Compliance

Frequently Asked Questions

Is BioHarvest Sciences Inc. - Common Stock publicly traded?
Yes, BioHarvest Sciences Inc. - Common Stock is publicly traded.
What exchange does BioHarvest Sciences Inc. - Common Stock trade on?
BioHarvest Sciences Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for BioHarvest Sciences Inc. - Common Stock?
The ticker symbol for BioHarvest Sciences Inc. - Common Stock is BHST on the Nasdaq Stock Market
What is the current price of BioHarvest Sciences Inc. - Common Stock?
The current price of BioHarvest Sciences Inc. - Common Stock is 3.920
When was BioHarvest Sciences Inc. - Common Stock last traded?
The last trade of BioHarvest Sciences Inc. - Common Stock was at 05/19/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.